Risk Of Developing Liver Cancer After HCV Treatment

Thursday, April 30, 2015

EASL 2015 Review - Internet symposium:The Advances in Chronic Hepatitis C: Management and Treatment program


CLICK HERE TO VIEW A REPLAY OF THE 4/27/15 PROGRAM

ViralEd has released a must watch Internet symposium with HCV experts discussing key data presented at this months EASL.

The Advances in Chronic Hepatitis C: Management and Treatment program
REPLAY from 4/27/15 is Available. Join program chair Mark Sulkowski, MD along with Fred Poordad, MD, Nezam Afdhal, MD and K. Rajender Reddy, MD as they review and discuss the key new studies from EASL 2015. 

Program Overview

The Advances in Chronic Hepatitis C: Management and Treatment program is a comprehensive, expert review of the 50th Annual Meeting of the European Association for the Study of the Liver (EASL 2015). This program consists of four components: (1) CME Internet Symposium: EASL 2015 Review: a 1.5 hour Internet symposium that features an overview and discussion of key presentations and posters, selected by the expert faculty discussants; (2) CME Internet Symposium: European Perspective on EASL 2015: a 1-hour Internet symposium featuring Europe-based expert faculty reviewing and discussing key presentations with a focus on management and treatment in the EU; (3) Rapid-Fire Review of EASL 2015: a podcast that provides a brief, audio summary of the most essential data presented at the conference; and (4) From Conference To Clinic: Reviewing And Applying Data From EASL 2015: case-based dinner meetings during which the key data are reviewed, discussed and applied to patient care.

The CME Internet Symposium: EASL 2015 Review will feature four HCV experts reviewing and discussing key presentations on chronic hepatitis C presented at EASL 2015. The review and discussion will focus on HCV therapeutic options and developments, including: current treatment and management strategies, algorithms and recommendations; therapies in development; epidemiology; and diagnosis and clinical management of specific patient populations, including HCV/HIV co-infected and cirrhotic patients.

This activity will enable participating health care providers caring for HCV-infected patients to become aware of and understand the data presented at this important conference and appropriately utilize those data to improve patient care. All online components of the program can be accessed at www.viraled.com.

This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc. It is not a session created by or presented at EASL 2015 and it is not sanctioned by the organizers of EASL 2015.

No comments:

Post a Comment